Latest Articles & Resources FEATURED Nanoform Signs U.S. Pharma Partnership for Biologics Technology Read More » Nanoform Signs U.S. Pharma Partnership for Biologics Technology Read More » LATEST NEWS + INTERVIEWS ERS Genomics Signs CRISPR Licensing Agreement with Aurigene Services Vetter Breaks Ground on €500 Million Injectable Drug Facility in Germany OrganaBio Acquires Excellos to Expand Cell Therapy CDMO Network How Kindeva’s $200M Sterile Injectable Investment Is Setting a New Compliance Benchmark for CDMOs Elpida Therapeutics Selects Catalent for Late-Phase AAV Manufacturing Charles River Laboratories Partners with MEDIPOST on Cell Therapy GMP Testing CDMO consolidation drives PE toward equipment and consumables ICON Opens 69,500 sq ft Early Phase CRU in San Antonio Alongside New Satellite Outpatient Clinics Veeda Lifesciences and Agilent Launch Joint CRO Center of Excellence for GLP-1 and Complex Biologics Analytics Understand Contract Packaging: Five Stages That Define a Successful Partnership Trump Confirms Makary Exit; Diamantas Named Acting Chief Andelyn Biosciences Launches LVV Curator Platform for Lentiviral Manufacturing Lakewood-Amedex Biotherapeutics Selects Specialist CRO PERI to Lead Phase 2 Trial of Nu-3 in Diabetic Foot Ulcers Lonza Launches Xcite AAV Stable Producer Cell Line Platform Avance Clinical Named Frost & Sullivan’s 2026 Global Biotechnology CRO of the Year Trisk Bio Partners with NanoMosaic on AAV Analytics Platform Cellares Partners with ProTgen on Automated T Cell Therapy Manufacturing Hovione Appoints Interim Co-CEOs Following CEO Transition VIVEbiotech Launches EvoLVcell Lentiviral Manufacturing Platform AGC Biologics Joins OTXL Clinical Development Network for Rare Disease Therapies Bora Pharmaceuticals Acquires MacroGenics Manufacturing Operations in Maryland PODCAST INTERVIEWS How Kindeva’s $200M Sterile Injectable Investment Is Setting a New Compliance Benchmark for CDMOs How PI Health Sciences Delivers Real-Time Visibility and Scientific Accountability Navigating Chaos: Jan Ramakers on Why the API Market Is Harder to Read Than Ever
Veeda Lifesciences and Agilent Launch Joint CRO Center of Excellence for GLP-1 and Complex Biologics Analytics
Lakewood-Amedex Biotherapeutics Selects Specialist CRO PERI to Lead Phase 2 Trial of Nu-3 in Diabetic Foot Ulcers
